SCHEMBL28028756

SCHEMBL28028756

O=CC1NCC(c2ccccc2)N1c1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.38
▸ MAPT P10636 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ GLA P06280 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ ATM Q13315 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ NT5E P21589 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27608566 0.79 GRM5 (0.33) —
SCHEMBL27957165 0.75 QPCT (0.43) —
SCHEMBL27590166 0.69 — —
SCHEMBL27523729 0.66 MAOA (0.40) ACHEMAPTALDH1A1L3MBTL1KDM4E
SCHEMBL27587863 0.65 SLC6A2 (0.57) MAPTALDH1A1KDM4EGLAGAA
SCHEMBL11064878 0.65 MEN1 (0.54) MAPTALDH1A1L3MBTL1KDM4EGLA
SCHEMBL27873206 0.64 KDM4E (0.38) MAPTALDH1A1KDM4EGAAMAPK1
SCHEMBL28743254 0.62 PRKCZ (0.44) ACHEGAAMEN1KMT2ALMNA
SCHEMBL11064115 0.62 MEN1 (0.58) MAPTALDH1A1L3MBTL1KDM4EGLA
SCHEMBL10575026 0.60 MAPT (0.58) MAPTALDH1A1KDM4EGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104781256-A 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel HOFFMANN LA ROCHE 2015-07-15 — — CN disclosed
Send feedback